Literature DB >> 8049424

Prognostic value of chromosomal abnormalities in follicular lymphoma.

H Tilly1, A Rossi, A Stamatoullas, B Lenormand, C Bigorgne, A Kunlin, M Monconduit, C Bastard.   

Abstract

The t(14;18)(q32;q21) chromosomal translocation is observed in more than 75% of cases of follicular lymphoma. Several additional chromosomal abnormalities, which might contribute to tumor progression, have also been described. However, prognostic implications of cytogenetic features in follicular lymphoma have not been clearly established. In an attempt to correlate cytogenetic findings with clinical outcome, we have studied survival and risk of transformation into a more aggressive lymphoma in 66 follicular lymphoma patients from whom a lymph node had been karyotyped at the time of diagnosis. A t(14;18) was the most common abnormality, having been observed in 51 patients (77%), but this showed no correlation with clinical outcome. Seventeen other recurrent numerical or structural abnormalities were identified in more than 10% of the patients. A high percentage of cells (> or = 90%) with abnormal metaphases and a number of chromosomal breaks higher than 6 were associated with a poor survival (P > .01 each). Patients with an abnormality of chromosome region 1p21-22 (P < .01), of 6q23-26 (P < .001), or of the short arm of chromosome 17 (P < .001) had a significantly shorter survival in univariate analysis. Multivariate analysis identified a break at 6q23-26 (P = .01) and 17p (P = .01) as independent prognostic factors in this population. The risk of transformation into a diffuse large-cell lymphoma was significantly higher in patients with either a 6q23-26 (P < .001) or a 17p (P < .01) abnormality. Chromosomal analysis of follicular lymphoma at the time of diagnosis can thus provide important information about the risk of transformation and survival.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8049424

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

1.  Chromosomal imbalances in primary lymphomas of the central nervous system.

Authors:  C H Rickert; B Dockhorn-Dworniczak; R Simon; W Paulus
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 2.  Clinical and molecular prognostic factors in follicular lymphoma.

Authors:  Andrew J Davies
Journal:  Curr Oncol Rep       Date:  2006-09       Impact factor: 5.075

3.  Detection of the bcl-2 t(14;18) translocation and proto-oncogene expression in primary intraocular lymphoma.

Authors:  Dana J Wallace; DeFen Shen; George F Reed; Masaru Miyanaga; Manabu Mochizuki; H Nida Sen; Samuel S Dahr; Ronald R Buggage; Robert B Nussenblatt; Chi-Chao Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

4.  Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation.

Authors:  Derville O'Shea; Ciarán O'Riain; Manu Gupta; Rachel Waters; Youwen Yang; David Wrench; John Gribben; Andreas Rosenwald; German Ott; Lisa M Rimsza; Harald Holte; Jean-Baptiste Cazier; Nathalie A Johnson; Elias Campo; Wing C Chan; Randy D Gascoyne; Bryan D Young; Louis M Staudt; T Andrew Lister; Jude Fitzgibbon
Journal:  Blood       Date:  2009-01-13       Impact factor: 22.113

Review 5.  Transformation of follicular lymphoma.

Authors:  Izidore S Lossos; Randy D Gascoyne
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-06       Impact factor: 3.020

Review 6.  Recent advances in the treatment of follicular lymphoma.

Authors:  Yukio Kobayashi
Journal:  Int J Clin Oncol       Date:  2009-07-11       Impact factor: 3.402

7.  Detection of chromosomal abnormalities by G-banding and prognostic impact in follicular lymphoma in the rituximab era.

Authors:  Taku Tsukamoto; Miki Kiyota; Eri Kawata; Nobuhiko Uoshima; Shotaro Tatekawa; Yoshiaki Chinen; Hisao Nagoshi; Shinsuke Mizutani; Yuji Shimura; Mio Yamamoto-Sugitani; Tsutomu Kobayashi; Shigeo Horiike; Satoru Yasukawa; Akio Yanagisawa; Masafumi Taniwaki; Junya Kuroda
Journal:  Int J Hematol       Date:  2016-12-19       Impact factor: 2.490

8.  Cytogenetic findings in 175 patients indicate that items of the Kiel classification should not be disregarded in the REAL classification of lymphoid neoplasms.

Authors:  H Nowotny; H Karlic; H Grüner; J Hirsch; M Vesely; A Nader; R Heinz
Journal:  Ann Hematol       Date:  1996-05       Impact factor: 3.673

9.  Specific synthetic lethal killing of RAD54B-deficient human colorectal cancer cells by FEN1 silencing.

Authors:  Kirk J McManus; Irene J Barrett; Yasaman Nouhi; Philip Hieter
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

10.  Translocation detection in lymphoma diagnosis by split-signal FISH: a standardised approach.

Authors:  Anke van Rijk; David Mason; Margaret Jones; José Cabeçadas; Mateus Crespo; Juan Cruz Cigudosa; Juan Fernando Garcia; Lorenzo Leoncini; Mario Cocco; Martin-Leo Hansmann; Anja Mottok; Christiane Copie Bergman; Maryse Baia; Dimitra Anagnostou; Evi Pouliou; Stephen Hamilton Dutoit; Mette Hjøllund Christiansen; Tim Svenstrup Poulsen; Steen Hauge Matthiesen; Jacques van Dongen; J Han van Krieken
Journal:  J Hematop       Date:  2008-08-29       Impact factor: 0.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.